Alpha 2.0
Login Register
» Articles » PMID: 15512878

Disease-modifying Drug Therapies

Overview
Journal Amyotroph Lateral Scler Other Motor Neuron Disord
Specialty Neurology
Date 2004 Oct 30
PMID 15512878
Citations 6
Authors
Benjamin R Brooks
Mohammed Sanjak
Affiliations
Soon will be listed here.
Citing Articles

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686].

Brooks B, Heiman-Patterson T, Wiedau-Pazos M, Liu S, Zhang J, Apple S PLoS One. 2022; 17(6):e0258614.

PMID: 35700157 PMC: 9197041. DOI: 10.1371/journal.pone.0258614.

Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym.

Longo D, Shoda L, Howell B, Coric V, Berman R, Qureshi I Toxicol Sci. 2020; 175(2):292-300.

PMID: 32040174 PMC: 7253195. DOI: 10.1093/toxsci/kfaa019.

Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.

Osman K, Kohlberg S, Mok A, Brooks R, Lind L, McCormack K Dysphagia. 2019; 35(2):343-359.

PMID: 31300881 PMC: 6954990. DOI: 10.1007/s00455-019-10034-9.

Amyotrophic Lateral Sclerosis: New Perpectives and Update.

Orsini M, Oliveira A, Nascimento O, Reis C, Araujo Leite M, Souza J Neurol Int. 2015; 7(2):5885.

PMID: 26487927 PMC: 4591493. DOI: 10.4081/ni.2015.5885.

Amyotrophic lateral sclerosis: one or multiple causes?.

Bastos A, Orsini M, Machado D, Mello M, Nader S, Silva J Neurol Int. 2011; 3(1):e4.

PMID: 21785676 PMC: 3141115. DOI: 10.4081/ni.2011.e4.